v3.26.1
XEROX HOLDINGS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (UNAUDITED) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues        
Total Revenues $ 1,922 $ 1,576 $ 3,768 $ 3,033
Costs and Expenses        
Research, development and engineering expenses 67 43 131 85
Selling, administrative and general expenses 432 368 862 746
Restructuring and related costs, net 23 10 68 9
Amortization of intangible assets 30 10 60 20
Divestitures 0 0 0 (4)
Non-financing interest expense [1],[2] 100 55 184 88
Other expenses (income), net [1] 5 25 (26) 60
Total Costs and Expenses 1,891 1,636 3,810 3,160
Income (Loss) before Income Taxes 31 (60) (42) (127)
Income tax expense 18 46 50 69
Net Income (Loss) 13 (106) (92) (196)
Less: Preferred stock dividends, net (3) (3) (7) (7)
Net Income (Loss) attributable to Common Shareholders $ 10 $ (109) $ (99) $ (203)
Basic Income (Loss) per Share (in dollars per share) $ 0.07 $ (0.87) $ (0.77) $ (1.62)
Diluted Income (Loss) per Share (in dollars per share) $ 0.07 $ (0.87) $ (0.77) $ (1.62)
Sales        
Revenues        
Total Revenues $ 996 $ 665 $ 1,916 $ 1,222
Costs and Expenses        
Cost of goods and services sold 579 480 1,179 862
Services, maintenance, rentals and other        
Revenues        
Total Revenues 926 911 1,852 1,811
Costs and Expenses        
Cost of goods and services sold $ 655 $ 645 $ 1,352 $ 1,294
[1] Prior year amounts have been reclassified to conform to the current year's presentation. Refer to Note 1 - Basis of Presentation for additional information
[2] Prior year amounts have been reclassified to conform to the current year's presentation. Refer to Note 1 - Basis of Presentation for additional information.